Accès ouvert

A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly started on dolutegravir

Article scientifique 2021 Anglais

Résumé

A group of Vanguard Community Health Centre doctors embarked on a Health System's Improvement (HSI) project with the aim of reducing harm to renal function in patients who were either commenced on or switched to a dolutegravir (DTG)-based antiretroviral therapy (ART) regimen since 2019, when the usual monitoring and evaluation of ART-regimen switches were disrupted by the coronavirus disease 2019 (COVID-19) pandemic. This intended harm-reduction exercise, involving a reflective process that was facilitated by the family physician, led to the development of a Vanguard Renal Protection Surveillance tool, which is now used at Vanguard to detect and prevent renal decline.

Citer ce document

Omar, J., Loftus, I., Vallie, N., Whitmore, R., Solomon, G., Powell, M., Mniki, S., Namane, M. (2021). A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly started on dolutegravir. https://doi.org/10.4102/phcfm.v13i1.3088

Accès au document

Voir sur le dépôt source

Ce document est hébergé sur son dépôt institutionnel d'origine.

Auteur(s)

Junaid Omar Izak Loftus Nabeelah Vallie Richard B. Whitmore Gaironesa Solomon Michelle Powell Samela Mniki Mosedi Namane

Statistiques

Consultations : 1

Téléchargements : 0